Perrigo Price to Sales Ratio 2010-2023 | PRGO
Historical PS ratio values for Perrigo (PRGO) over the last 10 years. The current P/S ratio for Perrigo as of April 18, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Perrigo P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-18 | 29.94 | 0.87 | |
| 2023-12-31 | 31.88 | $34.25 | 0.93 |
| 2023-09-30 | 31.37 | $34.29 | 0.91 |
| 2023-06-30 | 33.08 | $34.26 | 0.97 |
| 2023-03-31 | 34.66 | $33.86 | 1.02 |
| 2022-12-31 | 32.69 | $33.11 | 0.99 |
| 2022-09-30 | 33.92 | $32.80 | 1.03 |
| 2022-06-30 | 38.32 | $32.42 | 1.18 |
| 2022-03-31 | 36.06 | $31.43 | 1.15 |
| 2021-12-31 | 36.24 | $31.08 | 1.17 |
| 2021-09-30 | 43.80 | $30.10 | 1.46 |
| 2021-06-30 | 42.19 | $29.21 | 1.44 |
| 2020-12-31 | 40.70 | $29.76 | 1.37 |
| 2020-09-30 | 41.59 | $24.68 | 1.69 |
| 2020-06-30 | 49.86 | $24.90 | 2.00 |
| 2020-03-31 | 43.20 | $26.70 | 1.62 |
| 2019-12-31 | 46.21 | $27.23 | 1.70 |
| 2021-03-31 | 37.05 | $33.25 | 1.11 |
| 2019-09-30 | 49.79 | $34.39 | 1.45 |
| 2019-06-30 | 42.23 | $33.93 | 1.24 |
| 2019-03-31 | 42.50 | $34.07 | 1.25 |
| 2018-12-31 | 34.07 | $34.05 | 1.00 |
| 2018-09-30 | 62.24 | $34.40 | 1.81 |
| 2018-06-30 | 63.94 | $34.85 | 1.83 |
| 2018-03-31 | 72.90 | $34.93 | 2.09 |
| 2017-12-31 | 76.05 | $34.64 | 2.20 |
| 2017-09-30 | 73.73 | $34.93 | 2.11 |
| 2017-06-30 | 65.64 | $35.05 | 1.87 |
| 2017-03-31 | 57.58 | $35.77 | 1.61 |
| 2016-12-31 | 72.03 | $36.86 | 1.95 |
| 2016-09-30 | 79.77 | $20.57 | 3.88 |
| 2016-06-30 | 78.21 | $20.43 | 3.83 |
| 2016-03-31 | 110.18 | $17.94 | 6.14 |
| 2015-12-31 | 124.48 | $16.37 | 7.61 |
| 2015-09-30 | 135.18 | $30.45 | 4.44 |
| 2015-03-31 | 142.11 | $21.78 | 6.52 |
| 2014-12-31 | 143.38 | $22.39 | 6.40 |
| 2014-09-30 | 128.74 | $24.48 | 5.26 |
| 2014-06-30 | 124.85 | $27.25 | 4.58 |
| 2014-03-31 | 132.37 | $27.25 | 4.86 |
| 2013-12-31 | 131.26 | $29.51 | 4.45 |
| 2013-09-30 | 105.47 | $28.93 | 3.65 |
| 2013-06-30 | 103.36 | $27.24 | 3.79 |
| 2013-03-31 | 101.35 | $27.24 | 3.72 |
| 2012-12-31 | 88.72 | $25.77 | 3.44 |
| 2012-09-30 | 98.99 | $25.34 | 3.91 |
| 2012-06-30 | 100.42 | $24.90 | 4.03 |
| 2012-03-31 | 87.90 | $24.90 | 3.53 |
| 2011-12-31 | 82.72 | $24.02 | 3.44 |
| 2011-09-30 | 82.49 | $22.80 | 3.62 |
| 2011-06-30 | 74.58 | $21.95 | 3.40 |
| 2011-03-31 | 67.44 | $21.95 | 3.07 |
| 2010-12-31 | 53.66 | $20.37 | 2.63 |
| 2010-09-30 | 54.35 | $18.95 | 2.87 |
| 2010-06-30 | 49.94 | $17.73 | 2.82 |
| 2010-03-31 | 49.59 | $17.73 | 2.80 |
| 2009-12-31 | 33.59 | $17.35 | 1.94 |
| 2009-09-30 | 28.62 | $11.09 | 2.58 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.071B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Stryker (SYK) | United States | $127.849B | 31.70 |
| Medtronic (MDT) | Ireland | $105.004B | 14.86 |
| Boston Scientific (BSX) | United States | $99.704B | 33.15 |
| EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
| ResMed (RMD) | United States | $25.568B | 25.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
| Terumo (TRUMY) | Japan | $24.880B | 35.14 |
| Baxter (BAX) | United States | $20.069B | 14.64 |
| Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
| Insulet (PODD) | United States | $11.642B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
| Demant (WILYY) | Denmark | $10.001B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
| BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.378B | 15.97 |
| Envista Holdings (NVST) | United States | $3.367B | 12.80 |
| Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
| ICU Medical (ICUI) | United States | $2.336B | 17.43 |
| TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| Owens & Minor (OMI) | United States | $1.836B | 17.62 |
| Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
| InMode (INMD) | Israel | $1.465B | 7.59 |
| LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
| AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
| Warby Parker (WRBY) | United States | $1.189B | 0.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| MacroGenics (MGNX) | United States | $1.007B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
| BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
| Evolus (EOLS) | United States | $0.674B | 0.00 |
| Jin Medical (ZJYL) | China | $0.631B | 0.00 |
| Quanterix (QTRX) | United States | $0.602B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.538B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
| PetIQ (PETQ) | United States | $0.469B | 17.50 |
| ZimVie (ZIMV) | United States | $0.417B | 25.55 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.388B | 44.70 |
| Surmodics (SRDX) | United States | $0.378B | 40.80 |
| Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
| Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
| Veru (VERU) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Fonar (FONR) | United States | $0.105B | 8.98 |
| Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Safety Shot (SHOT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
| ProSomnus (OSA) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |